Genomic Prediction: Kelly Ketterson
Genomic Prediction has appointed Kelly Ketterson as chief operating officer. Ketterson previously served as vice resident of clinical operations at CooperSurgical, where she helped build the company's US Center of Excellence and embryology training program. She later served as CooperSurgical's medical affairs. Ketterson's other previous roles include those of chief operating officer at Reprogenics, executive director of Tyho-Galileo Research Laboratories and Althea Science, and executive director for several educational conferences focused on the continuing education of reproductive field specialists.